newsfilter
← Latest News
Business Wire·

Personalis Reports Third Quarter 2025 Financial Results

Company Advances "Win-in-MRD" Strategy with Compelling Clinical Trial Data and Increasing Physician Adoption of NeXT Personal® Platform Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for